Relenza

Active Ingredient(s): Zanamivir
FDA Approved: * July 26, 1999
Pharm Company: * GLAXOSMITHKLINE
Category: Antiviral

Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It is a neuraminidase inhibitor and was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B.[1] Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithK... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Relenza 5 mg/1 Respiratory (Inhalation) Powder
NDC: 0173-0681
Labeler:
Glaxosmithkline LLC
Relenza 5 mg/1 Respiratory (Inhalation) Powder
NDC: 54868-4377
Labeler:
Physicians Total Care, Inc.
Relenza 5 mg/1 Respiratory (Inhalation) Powder
NDC: 68258-3030
Labeler:
Dispensing Solutions Inc.

Popular Topics

Relenza for influenza

Does anyone have experience using Relenza to treat or prevent the flu? ## Hello, Ldkat! How are you? I've never take...

1 REPLY